Download presentation
Presentation is loading. Please wait.
Published byMarvin Moody Modified over 6 years ago
1
Updates in Anticoagulation: What Did We Learn From ESC 2017?
2
COMPASS: Trial Design
3
COMPASS: Pantoprazole-Based Randomization
4
COMPASS: Outcomes
5
COMPASS: Primary Endpoints CV Death, Stroke, MI
6
COMPASS: Primary Components
7
COMPASS: Major Bleeding
8
COMPASS: Net Clinical Benefit
9
COMPASS: Summary
10
RE-DUAL PCI: Study Design Multicenter, Randomized, Open-Label PROBE Trial
11
RE-DUAL PCI: Primary Endpoint ISTH Major or CRNM Bleeding Event
12
RE-DUAL PCI: Rates of TIMI Major or Minor Bleeding
13
RE-DUAL PCI: Summary
14
IMPACT-AF: Cluster Randomized Trial
15
IMPACT-AF: Results Persistence and New Treatment
16
IMPACT AF: Clinical Outcomes
17
EMANATE: Study Design
18
EMANATE: Stroke/SE Outcomes
19
XANTUS: A Worldwide Program
20
XANTUS: Efficacy and Safety in the Real World
21
REHEARSE-AF
22
Abbreviations
23
Abbreviations (cont)
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.